GlassScriptPhysician profile
Angela Pearson
NPI 1013267608
$3,068.55
in general payments reported to CMS, 2019-2025
16 companies · $512 in 2025
The $512 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $217 · 2022: $1,089 · 2023: $616 · 2024: $635 · 2025: $512.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,763.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,762.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $665.04 | 2021-2025 | |
| Sun Pharmaceutical Industries INC. | $510.42 | 2021-2025 | Blu-U, Ilumya, Absorica Ld |
| Genzyme Corporation | $309.38 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $296.39 | 2023-2025 | Sotyktu |
| Ucb, INC. | $256.21 | 2022-2024 | Cimzia, Bimzelx |
| Janssen Biotech, INC. | $202.29 | 2022-2025 | Tremfya, Stelara, Simponi |
| Pfizer INC. | $157.44 | 2022-2024 | |
| Lilly USA, LLC | $150.80 | 2021-2025 | Taltz, Ebglyss |
| Galderma Laboratories, L.P. | $143.17 | 2022 | |
| Organogenesis INC. | $101.60 | 2023 | Puraply |
| Regeneron Healthcare Solutions, INC. | $92.05 | 2022-2024 | Dupixent |
| Amgen INC. | $83.32 | 2022-2025 | Otezla |
| Novartis Pharmaceuticals Corporation | $42.29 | 2021-2023 | |
| Leo Pharma INC. | $21.85 | 2022 | |
| Incyte Corporation | $18.35 | 2024 | Opzelura |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $17.95 | 2024 | Eterna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angela Pearson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.